Prescription drug freight fraud, October 2025
Our analysis of large-scale commercial imports of semaglutide, tirzepatide, apixaban, pembrolizumab, and antibiotics from March to August of 2025 showed cancer drugs masquerading as antibiotics, semaglutide supposedly manufactured at a home hardware store, and over 120 kilograms of tirzepatide from unregistered facilities marked for compounding. Most of the shipments made it through U.S. ports of entry.
Read the report and learn more about pharmaceutical border security.
Examples of "fishy" shipments
A semaglutide shipment in March marked “for personal use” listed Brindlewood Home Hardware in Canada as its manufacturer.
An ordinary suburban address tied to a small IT consultancy was linked to 11 separate shipments claiming to be from Eli Lilly. The FDA refused them all, but the repeated attempts show the scale of fraudulent misrepresentation.